News
AstraZeneca's Breztri met primary goals in four asthma trials, including KALOS, LOGOS, LITHOS, and VATHOS, involving over ...
5d
Medindia on MSNWorld Asthma Day 2025: Making Inhalers a Right, Not a PrivilegeEnsuring global access to essential inhaled medications can drastically lower asthma-related deaths, especially in ...
Discover the errors undermining your asthma control, from improper inhaler technique to missing signs. These fixable mistakes ...
Wheezing, coughing, tired? You could be missing the silent asthma diagnosis. Doctor reveals signs to watch out for and ...
AstraZeneca said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for ...
AZ’s triple-combination therapy is already approved under the brand names Breztri Aerosphere and Trixeo Aerosphere to treat ...
AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...
Healthcare professionals play an essential role in tackling asthma-related challenges. By ensuring that patients are prescribed effective inhaled therapies—either alone or in combination with ...
8d
Clinical Trials Arena on MSNAstraZeneca’s triple-combo triumphs in two Phase III asthma trialsAstraZeneca plans to submit the positive data Breztri Aerosphere in asthma for to regulatory authorities for review.
Pulmonologists alarmed by climate-linked asthma surge, find hope in novel medications: Nandita Vijayasimha, Bengaluru Tuesday, May 6, 2025, 08:00 Hrs [IST] Pulmonologists associat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results